- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
106
Most Popular Stocks on the market
106 companies
Swedish Orphan Biovitrum
Market Cap: SEK 90.1b
An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 263.00
7D
4.9%
1Y
1.4%
Camurus
Market Cap: SEK 33.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMX
SEK 566.00
7D
4.3%
1Y
19.5%
Vitrolife
Market Cap: SEK 21.0b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 154.60
7D
2.0%
1Y
-8.0%
Bonesupport Holding
Market Cap: SEK 20.9b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 309.40
7D
3.6%
1Y
30.2%
AddLife
Market Cap: SEK 18.9b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 154.00
7D
7.1%
1Y
57.5%
BioArctic
Market Cap: SEK 14.7b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 168.10
7D
3.8%
1Y
-13.3%
BioGaia
Market Cap: SEK 10.3b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 100.70
7D
2.2%
1Y
-15.0%
Biotage
Market Cap: SEK 7.3b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 90.55
7D
3.7%
1Y
-44.6%
MedCap
Market Cap: SEK 5.8b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 385.50
7D
7.7%
1Y
-4.1%
Swedencare
Market Cap: SEK 5.8b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 35.60
7D
0.3%
1Y
-40.4%
Flerie
Market Cap: SEK 3.2b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 40.25
7D
-1.9%
1Y
n/a
BICO Group
Market Cap: SEK 2.7b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 35.86
7D
5.8%
1Y
-20.3%
Cereno Scientific
Market Cap: SEK 2.1b
Cereno Scientific AB (publ), clinical stage biotechnology company, develops therapeutics to treat cardiovascular and rare diseases worldwide.
CRNO B
SEK 7.62
7D
24.5%
1Y
76.6%
BioInvent International
Market Cap: SEK 1.8b
A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 27.85
7D
-2.3%
1Y
16.3%
Devyser Diagnostics
Market Cap: SEK 1.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 89.90
7D
1.6%
1Y
-14.4%
Vicore Pharma Holding
Market Cap: SEK 1.5b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 6.32
7D
-2.8%
1Y
-60.7%
Hansa Biopharma
Market Cap: SEK 1.5b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 21.98
7D
-0.6%
1Y
-24.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.
GENO
SEK 19.92
7D
8.7%
1Y
-30.3%
Egetis Therapeutics
Market Cap: SEK 1.3b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.38
7D
-14.7%
1Y
-45.5%
Xspray Pharma
Market Cap: SEK 1.2b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 35.60
7D
17.5%
1Y
-10.3%
SynAct Pharma
Market Cap: SEK 909.6m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 18.90
7D
-4.8%
1Y
181.9%
Enzymatica
Market Cap: SEK 837.4m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 3.43
7D
8.9%
1Y
1.5%
Saniona
Market Cap: SEK 836.9m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.
SANION
SEK 6.40
7D
-5.3%
1Y
239.3%
Diamyd Medical
Market Cap: SEK 811.9m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 7.82
7D
-2.5%
1Y
-20.2%
Hamlet BioPharma
Market Cap: SEK 745.4m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.30
7D
6.2%
1Y
97.2%
Infant Bacterial Therapeutics
Market Cap: SEK 679.0m
A clinical stage pharmaceutical company, develops drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 50.50
7D
-7.8%
1Y
-42.2%
Magle Chemoswed Holding
Market Cap: SEK 574.4m
Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.
MAGLE
SEK 28.60
7D
7.5%
1Y
-5.3%
FluoGuide
Market Cap: SEK 531.2m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 38.00
7D
3.5%
1Y
-15.0%
Dicot Pharma
Market Cap: SEK 503.4m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.28
7D
2.2%
1Y
27.9%
Orexo
Market Cap: SEK 496.2m
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 13.90
7D
-1.8%
1Y
-19.2%
Cinclus Pharma Holding
Market Cap: SEK 470.0m
A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.
CINPHA
SEK 10.18
7D
-8.9%
1Y
n/a
Promimic
Market Cap: SEK 453.4m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 24.50
7D
-12.2%
1Y
-14.0%
Oncopeptides
Market Cap: SEK 445.2m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.98
7D
-0.6%
1Y
-56.3%
Cantargia
Market Cap: SEK 372.9m
A biotechnology company, develops antibody-based treatments for life threatening diseases.
CANTA
SEK 1.57
7D
19.5%
1Y
-58.7%
Moberg Pharma
Market Cap: SEK 364.7m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 7.70
7D
6.9%
1Y
-71.6%
IRLAB Therapeutics
Market Cap: SEK 362.6m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 6.95
7D
-1.8%
1Y
-45.3%